Final Conference event - AFFECT-EU


The AFFECT-EU consortium is organising its Final Conference on Monday 18 March 2024 at the De Warande Club in Brussels, Rue Zinner 1, 1000 Bruxelles. This event will gather representatives from researchers, notified bodies, researchers, industry but also patients and healthcare professionals. It will notably contribute to share its insights on the research and findings revolving around Atrial Fibrilation Screening based on the work done by partners of the Consortium.


The Conference objectives are

  • To review the current state of Atrial Fibrilation Screening
  • To present the results of the EU Horizon H2020 AFFECT-EU project (2020–2024)
  • To consider how clinical experts and relevant stakeholders could consider integrating atrial fibrilation screening in their healthcare plans
  • To consider what developments and reforms are needed

The full programme of this event is available here

The venue for our final public event can accommodate approx. 100 people. Attendance is free, on a first-come-first-served basis, and there will also be a live webcast so that online participation will be possible for anyone who has pre-registered.



horizon2020AFFECT-EU receiving funding from the European Union’s Horizon 2020 research and innovation Programme under grant agreement N°847770. This reflects the authors’ view only. The Commission is not responsible for any use that may be made of the information it contains.

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic through Google Analytics. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services.

Copyright © 2020 - AFFECT-EU - All Rights Reserved - Privacy policy